Evidence map›Paper›PMID 42157264›Full record

ArticleJournal of cheminformatics2026

Novel molecular design via a scaffold-aware transformer with multi-scale attention mechanisms.

Junyoung Park, Sunyong Yoo

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Junyoung ParkDepartment of Intelligent Electronics and Computer Engineering, Chonnam National University, Gwangju, 61186, Republic of Korea.
Sunyong YooDepartment of Intelligent Electronics and Computer Engineering, Chonnam National University, Gwangju, 61186, Republic of Korea. syyoo@jnu.ac.kr.

Funding

Korea Health Industry Development Institute RS-2025-19252970Ministry of Food and Drug Safety RS-2024-00332003Ministry of Science and ICT, South Korea RS-2025-16063391
6 · The paper itself

Abstract

Recent advancements in artificial intelligence have demonstrated enhanced potential in accelerating drug discovery by exploring vast chemical spaces and predicting molecular properties. In particular, scaffold-constrained molecular generation has enabled the incorporation of structural constraints into the generation process. However, effectively integrating multi-scale structural information with activity-guided optimization remains challenging. To overcome these limitations, we propose a novel framework that integrates a transformer-based generative model and a graph attention network-based predictive model. The generative model produces molecules with desired structural characteristics by explicitly incorporating scaffold information, while the predictive model estimates the biological activity of the generated molecules. A supervised fine-tuning framework iteratively refines the generator through multi-stage tournament selection with experience memory. This framework guides the generator toward scaffold-consistent, high-affinity candidates while exploring novel chemical variations around a user-specified scaffold. Experimental results demonstrated that the proposed scaffold-aware transformer achieves competitive validity, uniqueness, and novelty, effectively generating novel compounds with high predicted binding affinity for biological targets. Meanwhile, an attention-based analysis extracted atom-level importance scores, highlighting the substructures that contribute to the predicted binding affinity and providing interpretable insights into structure-activity relationships. This study provides a practical and interpretable tool for scaffold-conditioned molecular generation.

Indexed as

AttentionDe novo molecular designDrug discoveryGenerative modelTransformer

Identifiers

PMID42157264
PMCPMC13425956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.